Translate
Pmv Pharmaceuticals Inc
About
Pmv Pharmaceuticals Inc (NASDAQ:PMVP) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
PMV Pharmaceuticals Announces Board Chair Transition
Mar 6 2026
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Feb 26 2026
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors
Nov 12 2025
PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights
Oct 24 2025
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
Recent Videos
Cómo invertir en Pmv Pharmaceuticals Inc (PMVP) paso a paso
Apr 11, 2026
How to Buy Shares of Pmv Pharmaceuticals Inc (PMVP)
Mar 24, 2026
PMV Pharmaceuticals, Inc. (PMVP) #PMVP #Rezatapopt #p53 #PrecisionOncology #OvarianCancer #Biotech
Mar 12, 2026
Update from ESGO 2026 – PYNNACLE Phase 2 study
Mar 03, 2026
Financials
Revenue
$0
Market Cap
$69.33 M
EPS
-1.48